CAPSTONE INVESTMENT ADVISORS, LLC
Institutional investor · Portfolio as of Q1 2026
SEC EDGAR SourceSEC Filings
CAPSTONE INVESTMENT ADVISORS, LLC manages $57.4B across 1558 positions as of Q1 2026. Top holdings: SPY (17.4%), QQQ (16.9%), QQQ (9.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Q1 2026 Summary
Active quarter - 327 new positions, 279 exits, 272 increased. Top move: AMZN (INCREASED, conviction 88). Portfolio: $57.4B across 1558 positions.
Top holdings by portfolio weight
SPY17.41%
QQQ16.95%
QQQ9.81%
AMZN2.60%
NVDA2.48%
MSFT2.21%
AMZN2.09%
MSFT1.79%
IVV1.77%
AAPL1.53%
Other1.41%
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Upgrade to Pro to see the worst-performing positions.
View plansCost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Top Holdings1,558 positions
Activity:
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction | |
|---|---|---|---|---|---|---|---|---|
STATE STR SPDR S&P 500 ETF T | 15.4M | $10B | 17.4% | — | — | — | Decreased — | |
INVESCO QQQ TR | 16.9M | $9.7B | 16.9% | — | — | — | Increased — | |
INVESCO QQQ TR | 9.8M | $5.6B | 9.8% | — | — | — | Increased — | |
AMAZON COM INC | 7.2M | $1.5B | 2.6% | — | — | — | Increased — | |
NVIDIA CORPORATION | 8.2M | $1.4B | 2.5% | — | — | — | Decreased — | |
MICROSOFT CORP | 3.4M | $1.3B | 2.2% | — | — | — | Increased — | |
AMAZON COM INC | 5.8M | $1.2B | 2.1% | $212.36 | +24.38% | 30 qtrssince 2018-Q4 | Increased 88 | |
MICROSOFT CORP | 2.8M | $1B | 1.8% | $414.35 | +3.12% | 30 qtrssince 2018-Q4 | Increased 81 | |
ISHARES TR | 1.6M | $1B | 1.8% | $624.24 | +18.94% | 9 qtrssince 2024-Q1 | Decreased 0 | |
APPLE INC | 3.5M | $877.3M | 1.5% | — | — | — | Increased — | |
Showing 10 of 1,558 results.1,548 more with Pro.PROUpgrade to see all → | ||||||||
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Security
4Q
04351PAD3ASCENDIS PHARMA A/S
Q2 2025 → Q1 2026+31.2M shares+$46.8M
38
4Q
163086AE1CHEFS WHSE INC
Q2 2025 → Q1 2026+27.4M shares+$41.8M
43
4Q
207410AH4CONMED CORP
Q2 2025 → Q1 2026+46M shares+$44.8M
37
Upgrade to Pro to see all accumulation streaks
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer